Suchergebnisse - "Deshpande, Chinmay"

PubPharm (28)

1

Real-world use of ofatumumab to treat multiple sclerosis 9 months post-FDA approval during COVID-19 pandemic

enthalten in: Multiple sclerosis and related disorders | 2023

von Coyle, P. | Gorritz, M. | Wade, R. | +5

2

Build-a-bug workshop : Using microbial-host interactions and synthetic biology tools to create cancer therapies

enthalten in: Cell host & microbe | 2023

von Raman, V. | Deshpande, C. | Khanduja, S. | +3

3

Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators

enthalten in: Multiple sclerosis and related disorders | 2023

von Sabatino, J. | Mittl, K. | Rowles, W. | +14

4

Real-world cost of care and site of care in patients with multiple sclerosis initiating infused disease-modifying therapies

enthalten in: Journal of medical economics | 2023

von Alvarez, E. | Nair, K. | Tan, H. | +5

5

Letter by Olson et al Regarding Article, "Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies : First Results From the RCT DUPLICATE Initiative"

enthalten in: Circulation | 2021

von Olson, M. | Deshpande, C. | Kahler, K.

CommentOn: Circulation. 2021 Mar 9;143(10):1002-1013. - PMID 33327727

6

Utilization and Treatment Patterns of Disease-Modifying Therapy in Pediatric Patients with Multiple Sclerosis in the United States

enthalten in: International journal of MS care | 2021

von Greenberg, B. | Kolodny, S. | Wang, M. | +1

7

Serum neurofilament levels and patient-reported outcomes in multiple sclerosis

enthalten in: Annals of clinical and translational neurology | 2021

von Galetta, K. | Deshpande, C. | Healy, B. | +10

8

Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis

enthalten in: Advances in therapy | 2021

von Nicholas, J. | Zhou, H. | Deshpande, C.

9

Serum neurofilament levels and patient‐reported outcomes in multiple sclerosis

enthalten in: Annals of Clinical and Translational Neurology | 2021

von Galetta, K. | Deshpande, C. | Healy, B. | +10

10

Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis

enthalten in: Advances in therapy | 2020

von Nicholas, J. | Zhou, H. | Deshpande, C.